510(k) Report

510(k) · Cleared

Cleared

Cholesterol2

K203597510(k) TraditionalCleared Jun 30, 2022568-day reviewClass I21 CFR 862.1175

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Ireland Diagnostics Division · CHH Enzymatic Esterase--Oxidase, Cholesterol

Cleared on Jun 30, 2022 as substantially equivalent to K981652 (Abbott Laboratories, 1998) after a 568-day review. Its family tree reaches back 2 generations to 1985.

Decided
Jun 30, 2022
Review
568 days
Class
Class I
Product code
CHH
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K854298 (1985). No later device cites it as a predicate yet.

K854298 · IRON · Boehringer Mannheim Corp. · 1985K981652 · CHOL · Abbott Laboratories · 19981990200020102020
  1. Root · 2 generations backK854298 IRONBoehringer Mannheim Corp. · 1985
  2. 1 generation backK981652 CHOLAbbott Laboratories · 1998
  3. This deviceK203597 Cholesterol2Abbott Ireland Diagnostics Division · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K854298IRONBoehringer Mannheim Corp.1985—
−1K981652CHOLAbbott Laboratories1998—
0 (this device)K203597Cholesterol2Abbott Ireland Diagnostics Division2022—
FIG. 1 — Lineage of K203597, 1985–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CHH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CHH device

  1. #1 K251091 Lipidsscore 10.9 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K981652CHOL
Summary page 5
…sification Name: Enzymatic esterase--oxidase, cholesterol Governing Regulation Number: 21 CFR §862.1175 Product Code: CHH IV. Predicate Device Cholesterol (k981652) V. Description of Device A. Principles of the Procedure Cholesterol esters are enzymatically hydrolyzed by cholest…
Abbott Laboratories1998—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 37 years and passes through 3 companies; a new generation was cleared every 24.0 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All CHH devices

CHH Enzymatic Esterase--Oxidase, Cholesterol: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · CHH

1in 2025

2007: 22008: 22009: 12011: 12012: 42013: 12014: 12015: 12016: 12017: 12018: 22019: 12022: 12024: 12025: 1
2007high 4 (2012) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CHH

198in 2012

2012: 198 days median
2007high 198 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CHH

2in 2021

2009: 32010: 22013: 12014: 12016: 22021: 22026 (partial year): 1
2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CHH

14in 2025

2007: 12010: 102011: 182012: 112014: 12016: 52017: 22018: 12019: 52020: 12021: 22022: 42023: 42024: 82025: 14
2007high 18 (2011) · low 0 (2008)2025

MAUDE reports naming product code CHH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—01
20082—00
20091—30
20100—210
20111—018
20124198011
20131—10
20141—11
20151—00
20161—25
20171—02
20182—01
20191—05
20200—01
20210—22
20221—04
20230—04
20241—08
20251—014
20260—1—

What is it indicated for?

The Cholesterol2 assay is used for the quantitation of cholesterol in human serum or plasma on the ARCHITECT c System. The Cholesterol2 assay is to be used an an aid in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K203597: Cholesterol2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K203597

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026